Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Bullboard Posts
Post by rhdmdon Feb 10, 2011 4:07pm
242 Views
Post# 18111915

No goevernment subsidy for Econiche is anticipated

No goevernment subsidy for Econiche is anticipatedOnly "guidelines". Feeble attempt by the government, I must say. We can stop all the speculation now. Only market demand will drive the sale. Sounds like another long wait folks. Is McRae jumping the gun again?

Please see Jennifer's detailed reply to my email:

TheCompany has three registered animal health products using MycobacterialCell Wall Extract (MCWE). These are immunotherapeutic products whichstimulate a network of non-specific immune system cells to fightinfection using the animal’s own immune system, rather than requiringantibiotics or other anti-infectives. The registered products are: Equimune® I.V., Immunoboost® and SETTLETM:

Equimune® I.V., sold in the United States and Australia, is a patented immunotherapeutic for the treatment of equine respiratory disease.

SETTLE™ wasapproved by the USDA in December 2004 as an aid in the treatment ofequine endometritis, a production limiting disease which affects 10% to20% of broodmares worldwide. The disease results in both low conceptionrates and loss of pregnancies, both of which are serious concerns forbreeders. SETTLE™ therapy can also be easily assimilated intoreproductive treatment protocols, offering the benefit of enhancing thebody’s own immune responses.

Sincerely,

Jennifer

/us.mc1612.mail.yahoo.com/mc/compose?to=Jennifer.Shea@Bioniche.com" target="_blank" rel="nofollow">Jennifer.Shea@Bioniche.com

www.Bioniche.com

Bullboard Posts